BCL2 and lung cancer: Consistently, Wnt activation has been shown as a driver of lung cancer metastasis,52,53 and has also been associated with metastasis in EC.54 In addition to cyclin D1 and fibronectin, our LIMMA analysis identified an upregulation of Stathmin and a downregulation of E-cadherin, Bcl-2 and ER.